# EDGAR Filing Document

**Accession Number:** 0000943819
**File Stem:** 0000943819-25-000082
**Filing Date:** 2025-10
**Character Count:** 4963
**Document Hash:** d573719b5f5d9bb626f89db915412fe8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000943819-25-000082.hdr.sgml**: 20251002

**ACCESSION NUMBER**: 0000943819-25-000082

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 4

**FILED AS OF DATE**: 20251002

**DATE AS OF CHANGE**: 20251002

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RESMED INC
- **CENTRAL INDEX KEY:** 0000943819
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 980152841
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15317
- **FILM NUMBER:** 251369836

**BUSINESS ADDRESS:**
- **STREET 1:** 9001 SPECTRUM CENTER BLVD.
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92123
- **BUSINESS PHONE:** 8587462400

**MAIL ADDRESS:**
- **STREET 1:** 9001 SPECTRUM CENTER BLVD.
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92123

![](resmedinc_defa14a2025xna001.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant  Filed by a Party other than the Registrant  Check the appropriate box:  Preliminary Proxy Statement  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))  Definitive Proxy Statement  Definitive Additional Materials  Soliciting Material Pursuant to § 240.14A-12 (Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): Payment of Filing Fee (Check all boxes that apply):  No fee required.  Fee paid previously with preliminary materials.  Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

------

![](resmedinc_defa14a2025xna002.jpg)

Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V79601-P37693 RESMED INC. 9001 SPECTRUM CENTER BLVD. SAN DIEGO, CA 92123 ATTN: SALLI SCHWARTZ Your Vote Counts! RESMED INC. 2025 Annual Meeting Date: November 19, 2025 Time: 3:00 p.m. (US Pacific Time) November 20, 2025 Time: 10:00 a.m. (Australian Eastern Time) Live webcast: Meeting live via the internet-please visit www.virtualshareholdermeeting.com/RMD2025 \*Please check the meeting materials for any special requirements for meeting attendance. Important notice regarding the availability of proxy materials for the stockholder meeting to be held on November 19, 2025 (US Time) / November 20, 2025 (Australian Time). You invested in RESMED INC. and it's time to vote! You have the right to vote on proposals being presented at the Annual Meeting. Get informed before you vote View the Notice, Proxy Statement, and Form 10-K online at www.ProxyVote.com, OR you can receive a free paper or email copy of the materials. If you would like to request a copy of the materials for this and/or future stockholder meetings, you may (1) visit http://www.ProxyVote.com, (2) call 1-800-579-1639, or (3) send an email to sendmaterial@ProxyVote.com, by November 5, 2025. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Virtually at: www.virtualshareholdermeeting.com/RMD2025 Vote Virtually at the Meeting\* November 19, 2025 at 3:00 p.m. (US Pacific Time) November 20, 2025 at 10:00 a.m. (Australian Eastern Time)

------

![](resmedinc_defa14a2025xna003.jpg)

Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click "Delivery Settings". Voting Items Board Recommends V79602-P37693 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. 1. Elect 11 directors, each to serve until our 2026 annual meeting and until their successors are elected and qualified. The nominees for election as directors at the 2025 annual meeting are: 1a. Carol Burt For 1b. Christopher DelOrefice For 1c. Jan De Witte For 1d. Karen Drexler For 1e. Michael Farrell For 1f. Peter Farrell For 1g. Harjit Gill For 1h. John Hernandez For 1i. Nicole Mowad-Nassar For 1j. Desney Tan For 1k. Ronald Taylor For 2. Ratify our selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending June 30, 2026. For 3. Approve, on an advisory basis, the compensation paid to our named executive officers. For 4. Approve the amendment and restatement of our 2009 Incentive Award Plan. For 5. Approve the amendment and restatement of our 2018 Employee Stock Purchase Plan. For

------